Open AccessEffect of ranibizumab on serous and vascular pigment epithelial detachments associated with exudative age-related macular degeneration
Author(s) -
Georgios D. Panos,
Zisis Gatzioufas,
Petropoulos,
Dardabounis,
Thumann,
Hafezi
Publication year - 2013
Publication title -
drug design development and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.964
H-Index - 64
ISSN - 1177-8881
DOI - 10.2147/dddt.s46610
Subject(s) - ranibizumab , medicine , macular degeneration , ophthalmology , serous fluid , visual acuity , retinal , retinal pigment epithelium , prospective cohort study , choroidal neovascularization , bevacizumab , surgery , chemotherapy
To report the effect of intravitreal ranibizumab therapy for serous and vascular pigment epithelial detachments (PED) associated with choroidal neovascularisation (CNV) secondary to age-related macular degeneration (AMD).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom